Navigation Links
Bioequivalence and Bioavailability Survey Report
Date:6/23/2011

(IR) relevance through integrated modelling and simulation of PK/PD- efficacy/safety - Case Study from Merck
  • Challenges in the design of comparative bioavailability studies: experiences from industry - Case Study from Synthon BV
  • Industry experience with the EMA bioequivalence guideline - Case Study from EGA Bioequivalence Working Group

    • Tips from the regulators for successfully securing a biowaiver (State Institute for Drug Control, Czech Republic)

    To access the full survey report or to find out more about Bioequivalence and Bioavailability Studies 2011 please visit Bioequivalence and Bioavailability page, email  enquire@iqpc.co.uk or call +44(0)2073689421

    Media contact: Joanna Checinska, +44(0)20-7368-9421, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.

    Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (joanna.checinska@iqpc.co.uk)



    '/>"/>
    SOURCE Pharma IQ
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
    2. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
    3. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
    4. MannKind Reports Successful Completion of Device Bioequivalence Trial
    5. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
    6. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
    7. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
    8. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
    9. NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
    10. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
    11. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
    (Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
    (Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
    Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
    (Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
    (Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
    (Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
    (Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
    (Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
    Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
    ... -16 April, is taking full advantage of its Geneva ... of the World Health Organisation (WHO), the World Heart ... the International Olympics Committee (IOC). On Thursday 14 ... (EACPR) will host joint sessions including a session looking ...
    ... With efforts underway to ban lead-based ammunition as a ... evidence that a prime alternative material for bullets ... report, which found that tungsten accumulates in major structures ... journal Chemical Research in Toxicology . Jose ...
    ... FL (April 6, 2011) Numerous studies show that ... cancer. However, animal studies testing the NSAID naproxen or ... formation. Now, researchers at Fox Chase Cancer Center find ... strain of mutant mice that spontaneously develop colon tumors. ...
    ... By Serena Gordon HealthDay Reporter , ... analysis from the Women,s Health Initiative (WHI) study, researchers ... estrogen-only hormone therapy faded rapidly after they ended the ... stopped taking estrogen, the risk of stroke and blood ...
    ... , WEDNESDAY, April 6 (HealthDay News) -- Compared ... to experience bleeding and infections during and after a ... analyzed data from 20,353 women who had a hysterectomy ... menstruation, benign muscle tumors and pain. Women with ...
    ... strawberries may be a way to help people at risk ... a new study by researchers at The Ohio State University ... Richard J. Solove Research Institute (OSUCCC James) and researchers ... during a press briefing at 8 a.m. April 6 at ...
    Cached Medicine News:Health News:International organizations join forces to promote cardiovascular health 2Health News:International organizations join forces to promote cardiovascular health 3Health News:Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 3Health News:Weight Linked to Complications in Some Hysterectomy Patients 2Health News:An international study in China finds strawberries may slow precancerous growth in the esophagus 2Health News:An international study in China finds strawberries may slow precancerous growth in the esophagus 3
    Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
    Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
    Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 50 OD...
    Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
    Medicine Products: